We aim to provide helpful information to our readers, but cannot provide a treatment, diagnosis, or consultation of any sort, and we are in no way indicating that any particular drug is safe or appropriate for you and your individual needs
PCAB-accredited with a strong reputation for safety and quality
GLP-1 Compliance FAQs The answer depends on several factors, including whether your pharmacy operates under 503A or 503B, the current FDA shortage designation status, and whether the specific drug or its base compound appears on the FDA's list of bulk drug substances
This article covers the real causes behind dark spots on the lips, from the most common and completely harmless to the few that warrant a medical evaluation
Given the results from recent studies, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend that patients with T2D and clinical cardiovascular disease (CVD) with inadequate glucose control despite treatment with metformin should receive an SGLT2 inhibitor or GLP-1 receptor agonist
We've mentioned it multiple times, but it bears repeating